| DC Field | Value | Language |
|---|
| dc.contributor.author | Kosman, V. M. | - |
| dc.contributor.author | Faustova, N. M. | - |
| dc.contributor.author | Karlina, M. V. | - |
| dc.contributor.author | Makarov, V. G. | - |
| dc.contributor.author | Makarova, M. N. | - |
| dc.date.accessioned | 2022-05-11T14:28:47Z | - |
| dc.date.available | 2022-05-11T14:28:47Z | - |
| dc.date.issued | 2022 | - |
| dc.identifier.citation | Study of pharmacokinetic of new peptide drug 1-deamino-arginine-vasotocin for hypernatremia correction / V.M. Kosman [et al.] // Research Results in Pharmacology. - 2022. - Vol.8, №1.-P. 23-31. - Doi: 10.3897/rrpharmacology.8.71802. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/46671 | - |
| dc.description.abstract | The pharmacokinetics studies are some of the necessary parts of the drugs preclinical investigations. Pharmacokinetic properties of new peptide drug 1-deamino-arginine-vasotocin (dAVT) in the form of an injection solution for intravenous and intramuscular administration for hypernatremia correction were investigated | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | 1-deamino-arginine-vasotocin | ru |
| dc.subject | solution for injection | ru |
| dc.subject | parenteral administration | ru |
| dc.subject | pharmacokinetics | ru |
| dc.subject | rats | ru |
| dc.subject | rabbits | ru |
| dc.subject | plasma | ru |
| dc.subject | sodium level | ru |
| dc.title | Study of pharmacokinetic of new peptide drug 1-deamino-arginine-vasotocin for hypernatremia correction | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 8, № 1
|
